$93.4 Million is the total value of Polaris Venture Management Co. V, L.L.C.'s 9 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SELB | Selecta Biosciences, Inc. | $27,554,000 | -16.5% | 1,924,151 | 0.0% | 29.50% | -24.7% | |
| PULM | Pulmatrix Inc. | $12,592,000 | +491.5% | 3,607,996 | 0.0% | 13.48% | +433.4% | |
| GNCA | Genocea Biosciences, Inc. | $11,989,000 | +47.8% | 1,968,606 | 0.0% | 12.83% | +33.3% | |
| FATE | Fate Therapeutics, Inc. | $11,253,000 | +81.3% | 2,473,186 | 0.0% | 12.05% | +63.5% | |
| TTOO | T2 Biosystems, Inc. | $9,865,000 | 0.0% | 1,875,524 | 0.0% | 10.56% | -9.8% | |
| TRVN | Trevena, Inc. | $7,536,000 | -37.6% | 2,053,540 | 0.0% | 8.07% | -43.7% | |
| LIFE | Atyr Pharma Inc. | $6,398,000 | +62.8% | 1,827,992 | 0.0% | 6.85% | +46.8% | |
| OCUL | Sell | Ocular Therapeutix, Inc. | $3,556,000 | -46.1% | 383,141 | -51.4% | 3.81% | -51.4% |
| CERU | Cerulean Pharma Inc | $2,671,000 | +14.7% | 3,287,529 | 0.0% | 2.86% | +3.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Fate Therapeutics, Inc. | 30 | Q2 2021 | 79.2% |
| Atyr Pharma Inc. | 26 | Q3 2021 | 15.1% |
| Trevena, Inc. | 22 | Q2 2019 | 24.9% |
| Genocea Biosciences, Inc. | 21 | Q1 2019 | 32.5% |
| Selecta Biosciences, Inc. | 20 | Q1 2021 | 39.5% |
| T2 Biosystems, Inc. | 20 | Q2 2019 | 36.1% |
| Dare Bioscience, Inc. | 17 | Q3 2021 | 3.9% |
| Pulmatrix, Inc. | 16 | Q1 2019 | 15.4% |
| Cerulean Pharma Inc | 13 | Q2 2017 | 16.2% |
| Kala Pharmaceuticals, Inc. | 11 | Q1 2020 | 37.1% |
View Polaris Venture Management Co. V, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2022-03-30 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-12 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-14 |
| 4 | 2020-05-06 |
| 3 | 2020-04-30 |
View Polaris Venture Management Co. V, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.